202 related articles for article (PubMed ID: 7562572)
1. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
2. E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.
Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
Z Gastroenterol; 1987 Apr; 25(4):201-6. PubMed ID: 2884786
[TBL] [Abstract][Full Text] [Related]
3. Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding.
Keith RH; Tsai BS; Collins PW; Perkins WE; Shone RL; Gasiecki AF; Bianchi RG; Bauer RF
Prostaglandins; 1992 Dec; 44(6):579-95. PubMed ID: 1335587
[TBL] [Abstract][Full Text] [Related]
4. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid.
Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
Am J Med; 1987 Jul; 83(1A):9-14. PubMed ID: 2887113
[TBL] [Abstract][Full Text] [Related]
6. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.
Tsai BS; Kessler LK; Stolzenbach J; Schoenhard G; Bauer RF
Dig Dis Sci; 1991 May; 36(5):588-93. PubMed ID: 1850690
[TBL] [Abstract][Full Text] [Related]
7. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
Perkins WE; Bianchi RG; Tremont SJ; Collins PW; Casler JJ; Fenton RL; Wagner GM; McGrath MP; Stolzenbach JC; Kowalski DL
J Pharmacol Exp Ther; 1994 Apr; 269(1):151-6. PubMed ID: 8169819
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
9. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells.
Tsai BS; Kessler LK; Collins P; Kramer S; Bauer RF
Prostaglandins; 1987; 33 Suppl():30-9. PubMed ID: 2827238
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
Wilson DE
Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
[TBL] [Abstract][Full Text] [Related]
13. GR63799X--a novel prostanoid with selectivity for EP3 receptors.
Bunce KT; Clayton NM; Coleman RA; Collington EW; Finch H; Humphray JM; Humphrey PP; Reeves JJ; Sheldrick RL; Stables R
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():379-82. PubMed ID: 1825574
[No Abstract] [Full Text] [Related]
14. The prostaglandin analogs, misoprostol and SC-46275, potently inhibit cytokine release from activated human monocytes.
Widomski D; Fretland DJ; Gasiecki AF; Collins PW
Immunopharmacol Immunotoxicol; 1997 May; 19(2):165-74. PubMed ID: 9130003
[TBL] [Abstract][Full Text] [Related]
15. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
[TBL] [Abstract][Full Text] [Related]
16. Effects of misoprostol and omeprazole on basal gastric pH and free acid content in horses.
Sangiah S; MacAllister CC; Amouzadeh HR
Res Vet Sci; 1989 Nov; 47(3):350-4. PubMed ID: 2512598
[TBL] [Abstract][Full Text] [Related]
17. SC-46275: a potent and highly selective agonist at the EP3 receptor.
Savage MA; Moummi C; Karabatsos PJ; Lanthorn TH
Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):939-43. PubMed ID: 8140121
[TBL] [Abstract][Full Text] [Related]
18. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
Buzás G; Puscas I; Persa F; Reznicek A
Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandins inhibit secretion of histamine and pancreastatin from isolated rat stomach ECL cells.
Lindström E; Håkanson R
Br J Pharmacol; 1998 Jul; 124(6):1307-13. PubMed ID: 9720805
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
Bertaccini G; Adami M; Coruzzi G
Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
